Selected research
Market Structure
Global Pain Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pain Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pain Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pain Management include Yunnan Baiyao, Teva, Sanofi, J&J, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Pain Management market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pain Management and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pain Management revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pain Management market size, projected growth trends, production technologies, key applications, and end-use industries.
Pain Management Segment by Company
Yunnan Baiyao
Teva
Sanofi
J&J
Merck
Eli Lilly
Pfizer
GSK
Bayer
AstraZeneca
Purdue
Grunenthal
Endo
Depomed
Allergan
Pain Management Segment by Type
Branded Opioids
NSAIDs
Generic Opioids
Others
Pain Management Segment by Application
Hospitals
Clinics
Others
Pain Management Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pain Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pain Management industry.
Chapter 3: Detailed analysis of Pain Management companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pain Managementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Branded Opioids
- NSAIDs
- Generic Opioids
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Yunnan Baiyao
- Teva
- Sanofi
- J&J
- Merck
- Eli Lilly
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Purdue
- Grunenthal
- Endo
- Depomed
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Pain Management Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Branded Opioids
- 1.2.3 NSAIDs
- 1.2.4 Generic Opioids
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Pain Management Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Pain Management Growth Trends by Region
- 1.5.1 Global Pain Management Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Pain Management Market Size by Region (2021-2026)
- 1.5.3 Pain Management Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Pain Management Market Dynamics
- 2.1 Pain Management Industry Trends
- 2.2 Pain Management Industry Drivers
- 2.3 Pain Management Industry Opportunities and Challenges
- 2.4 Pain Management Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Pain Management Revenue by Company (2021-2026)
- 3.2 Global Pain Management Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Pain Management Key Company Head office and Area Served
- 3.4 Global Pain Management Company, Product Type & Application
- 3.5 Global Pain Management Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Pain Management Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Pain Management Players Market Share by Revenue in 2025
- 3.6.3 2025 Pain Management Tier 1, Tier 2, and Tier 3
4 Pain Management Market by Type
- 4.1 Global Pain Management Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Pain Management Market Size by Type (2021-2032)
- 4.3 Global Pain Management Market Size Share by Type (2021-2032)
5 Pain Management Market by Application
- 5.1 Global Pain Management Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Pain Management Market Size by Application (2021-2032)
- 5.3 Global Pain Management Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Yunnan Baiyao
- 6.1.1 Yunnan Baiyao Company Information
- 6.1.2 Yunnan Baiyao Business Overview
- 6.1.3 Yunnan Baiyao Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Yunnan Baiyao Pain Management Product Portfolio
- 6.1.5 Yunnan Baiyao Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Teva Pain Management Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Sanofi Pain Management Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 J&J
- 6.4.1 J&J Company Information
- 6.4.2 J&J Business Overview
- 6.4.3 J&J Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 J&J Pain Management Product Portfolio
- 6.4.5 J&J Recent Developments
- 6.5 Merck
- 6.5.1 Merck Company Information
- 6.5.2 Merck Business Overview
- 6.5.3 Merck Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Merck Pain Management Product Portfolio
- 6.5.5 Merck Recent Developments
- 6.6 Eli Lilly
- 6.6.1 Eli Lilly Company Information
- 6.6.2 Eli Lilly Business Overview
- 6.6.3 Eli Lilly Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Eli Lilly Pain Management Product Portfolio
- 6.6.5 Eli Lilly Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pfizer Pain Management Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 GSK
- 6.8.1 GSK Company Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 GSK Pain Management Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Bayer Pain Management Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 AstraZeneca Pain Management Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Purdue
- 6.11.1 Purdue Company Information
- 6.11.2 Purdue Business Overview
- 6.11.3 Purdue Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Purdue Pain Management Product Portfolio
- 6.11.5 Purdue Recent Developments
- 6.12 Grunenthal
- 6.12.1 Grunenthal Company Information
- 6.12.2 Grunenthal Business Overview
- 6.12.3 Grunenthal Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Grunenthal Pain Management Product Portfolio
- 6.12.5 Grunenthal Recent Developments
- 6.13 Endo
- 6.13.1 Endo Company Information
- 6.13.2 Endo Business Overview
- 6.13.3 Endo Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Endo Pain Management Product Portfolio
- 6.13.5 Endo Recent Developments
- 6.14 Depomed
- 6.14.1 Depomed Company Information
- 6.14.2 Depomed Business Overview
- 6.14.3 Depomed Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Depomed Pain Management Product Portfolio
- 6.14.5 Depomed Recent Developments
- 6.15 Allergan
- 6.15.1 Allergan Company Information
- 6.15.2 Allergan Business Overview
- 6.15.3 Allergan Pain Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Allergan Pain Management Product Portfolio
- 6.15.5 Allergan Recent Developments
7 North America
- 7.1 North America Pain Management Market Size (2021-2032)
- 7.2 North America Pain Management Market Size by Type
- 7.2.1 North America Pain Management Market Size by Type (2021-2026)
- 7.2.2 North America Pain Management Market Size by Type (2027-2032)
- 7.2.3 North America Pain Management Market Share by Type (2021-2032)
- 7.3 North America Pain Management Market Size by Application
- 7.3.1 North America Pain Management Market Size by Application (2021-2026)
- 7.3.2 North America Pain Management Market Size by Application (2027-2032)
- 7.3.3 North America Pain Management Market Share by Application (2021-2032)
- 7.4 North America Pain Management Market Size by Country
- 7.4.1 North America Pain Management Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Pain Management Market Size by Country (2021-2026)
- 7.4.3 North America Pain Management Market Size by Country (2027-2032)
- 7.4.4 North America Pain Management Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Pain Management Market Size (2021-2032)
- 8.2 Europe Pain Management Market Size by Type
- 8.2.1 Europe Pain Management Market Size by Type (2021-2026)
- 8.2.2 Europe Pain Management Market Size by Type (2027-2032)
- 8.2.3 Europe Pain Management Market Share by Type (2021-2032)
- 8.3 Europe Pain Management Market Size by Application
- 8.3.1 Europe Pain Management Market Size by Application (2021-2026)
- 8.3.2 Europe Pain Management Market Size by Application (2027-2032)
- 8.3.3 Europe Pain Management Market Share by Application (2021-2032)
- 8.4 Europe Pain Management Market Size by Country
- 8.4.1 Europe Pain Management Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Pain Management Market Size by Country (2021-2026)
- 8.4.3 Europe Pain Management Market Size by Country (2027-2032)
- 8.4.4 Europe Pain Management Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Pain Management Market Size (2021-2032)
- 9.2 China Pain Management Market Size by Type
- 9.2.1 China Pain Management Market Size by Type (2021-2026)
- 9.2.2 China Pain Management Market Size by Type (2027-2032)
- 9.2.3 China Pain Management Market Share by Type (2021-2032)
- 9.3 China Pain Management Market Size by Application
- 9.3.1 China Pain Management Market Size by Application (2021-2026)
- 9.3.2 China Pain Management Market Size by Application (2027-2032)
- 9.3.3 China Pain Management Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Pain Management Market Size (2021-2032)
- 10.2 Asia Pain Management Market Size by Type
- 10.2.1 Asia Pain Management Market Size by Type (2021-2026)
- 10.2.2 Asia Pain Management Market Size by Type (2027-2032)
- 10.2.3 Asia Pain Management Market Share by Type (2021-2032)
- 10.3 Asia Pain Management Market Size by Application
- 10.3.1 Asia Pain Management Market Size by Application (2021-2026)
- 10.3.2 Asia Pain Management Market Size by Application (2027-2032)
- 10.3.3 Asia Pain Management Market Share by Application (2021-2032)
- 10.4 Asia Pain Management Market Size by Country
- 10.4.1 Asia Pain Management Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Pain Management Market Size by Country (2021-2026)
- 10.4.3 Asia Pain Management Market Size by Country (2027-2032)
- 10.4.4 Asia Pain Management Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Pain Management Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Pain Management Market Size by Type
- 11.2.1 South America, Middle East & Africa Pain Management Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Pain Management Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Pain Management Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Pain Management Market Size by Application
- 11.3.1 South America, Middle East & Africa Pain Management Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Pain Management Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Pain Management Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Pain Management Market Size by Country
- 11.4.1 South America, Middle East & Africa Pain Management Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Pain Management Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Pain Management Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Pain Management Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst